ESR1 and breast carcinoma: In a retrospective cohort study of 437 breast cancer patients, elevated levels of TSH were associated with a lower likelihood of triple positive breast cancer (ER+ PR+ Her2/neu+) compared with ER+ PR+ Her2/neu– breast cancer.